• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT2 通过细胞外蛋白去乙酰化促进肺癌转移。

Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.

机构信息

Institute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.

Institutes of Biological and Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, 215123, China.

出版信息

Adv Sci (Weinh). 2023 Jan;10(3):e2205462. doi: 10.1002/advs.202205462. Epub 2022 Dec 1.

DOI:10.1002/advs.202205462
PMID:36453571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9875677/
Abstract

Acetylation of extracellular proteins has been observed in many independent studies where particular attention has been given to the dynamic change of the microenvironmental protein post-translational modifications. While extracellular proteins can be acetylated within the cells prior to their micro-environmental distribution, their deacetylation in a tumor microenvironment remains elusive. Here it is described that multiple acetyl-vWA domain-carrying proteins including integrin β3 (ITGB3) and collagen 6A (COL6A) are deacetylated by Sirtuin family member SIRT2 in extracellular space. SIRT2 is secreted by macrophages following toll-like receptor (TLR) family member TLR4 or TLR2 activation. TLR-activated SIRT2 undergoes autophagosome translocation. TNF receptor associated factor 6 (TRAF6)-mediated autophagy flux in response to TLR2/4 activation can then pump SIRT2 into the microenvironment to function as extracellular SIRT2 (eSIRT2). In the extracellular space, eSIRT2 deacetylates ITGB3 on aK416 involved in cell attachment and migration, leading to a promotion of cancer cell metastasis. In lung cancer patients, significantly increased serum eSIRT2 level correlates with dramatically decreased ITGB3-K416 acetylation in cancer cells. Thus, the extracellular space is a subcellular organelle-like arena where eSIRT2 promotes cancer cell metastasis via catalyzing extracellular protein deacetylation.

摘要

细胞外蛋白的乙酰化作用在许多独立的研究中都有观察到,其中特别关注了微环境中蛋白质翻译后修饰的动态变化。虽然细胞外蛋白在其进入微环境分布之前就可以被乙酰化,但其在肿瘤微环境中的去乙酰化作用仍然难以捉摸。在这里描述了,包括整合素 β3(ITGB3)和胶原 6A(COL6A)在内的多种携带乙酰-vWA 结构域的蛋白在细胞外空间被 Sirtuin 家族成员 SIRT2 去乙酰化。SIRT2 是由巨噬细胞在 Toll 样受体(TLR)家族成员 TLR4 或 TLR2 激活后分泌的。TLR 激活的 SIRT2 经历自噬体易位。然后,TNF 受体相关因子 6(TRAF6)介导的自噬通量对 TLR2/4 激活的反应可以将 SIRT2 泵入微环境中,作为细胞外 SIRT2(eSIRT2)发挥作用。在细胞外空间,eSIRT2 去乙酰化 ITGB3 上的 aK416,该位点参与细胞附着和迁移,导致癌细胞转移的促进。在肺癌患者中,血清中 eSIRT2 水平显著升高与癌细胞中 ITGB3-K416 乙酰化程度显著降低相关。因此,细胞外空间是一个类似细胞内细胞器的场所,其中 eSIRT2 通过催化细胞外蛋白去乙酰化作用促进癌细胞转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/04fcf6bc6f36/ADVS-10-2205462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/84fa26fdb03a/ADVS-10-2205462-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/ea57eb840400/ADVS-10-2205462-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/0137d63b838d/ADVS-10-2205462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/95a20b37e48e/ADVS-10-2205462-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/bbac02abe030/ADVS-10-2205462-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/91f6c3087976/ADVS-10-2205462-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/98ce63e8dbaa/ADVS-10-2205462-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/58eb82841165/ADVS-10-2205462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/04fcf6bc6f36/ADVS-10-2205462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/84fa26fdb03a/ADVS-10-2205462-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/ea57eb840400/ADVS-10-2205462-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/0137d63b838d/ADVS-10-2205462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/95a20b37e48e/ADVS-10-2205462-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/bbac02abe030/ADVS-10-2205462-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/91f6c3087976/ADVS-10-2205462-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/98ce63e8dbaa/ADVS-10-2205462-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/58eb82841165/ADVS-10-2205462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e466/9875677/04fcf6bc6f36/ADVS-10-2205462-g005.jpg

相似文献

1
Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.SIRT2 通过细胞外蛋白去乙酰化促进肺癌转移。
Adv Sci (Weinh). 2023 Jan;10(3):e2205462. doi: 10.1002/advs.202205462. Epub 2022 Dec 1.
2
Multifaceted regulation of sirtuin 2 (Sirt2) deacetylase activity.Sirtuin 2(Sirt2)去乙酰化酶活性的多方面调节。
J Biol Chem. 2024 Sep;300(9):107722. doi: 10.1016/j.jbc.2024.107722. Epub 2024 Aug 28.
3
SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases.SIRT2 依赖性 IDH1 去乙酰化抑制结直肠癌和肝转移。
EMBO Rep. 2020 Apr 3;21(4):e48183. doi: 10.15252/embr.201948183. Epub 2020 Mar 5.
4
Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice.抑制 SIRT2 可促进 APP 乙酰化,改善 APP/PS1 转基因小鼠的认知障碍。
Cell Rep. 2022 Jul 12;40(2):111062. doi: 10.1016/j.celrep.2022.111062.
5
SIRT2 regulates oxidative stress-induced cell death through deacetylation of c-Jun NH-terminal kinase.SIRT2 通过去乙酰化 c-Jun NH2-末端激酶调节氧化应激诱导的细胞死亡。
Cell Death Differ. 2018 Sep;25(9):1638-1656. doi: 10.1038/s41418-018-0069-8. Epub 2018 Feb 15.
6
Involvement of acetylation of ATG4B in controlling autophagy induction.ATG4B 乙酰化在控制自噬诱导中的作用。
Autophagy. 2023 Mar;19(3):1039-1041. doi: 10.1080/15548627.2022.2117887. Epub 2022 Sep 2.
7
The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.SIRT2 介导的 AKR1C1 去乙酰化对于抑制其在非小细胞肺癌中的促转移功能是必需的。
Theranostics. 2020 Jan 12;10(5):2188-2200. doi: 10.7150/thno.39151. eCollection 2020.
8
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.Sirtuin 2(SIRT2)和组蛋白 H3K18 乙酰化途径的失调与不良的前列腺癌结局相关。
BMC Cancer. 2017 Dec 20;17(1):874. doi: 10.1186/s12885-017-3853-9.
9
The SIRT2 deacetylase regulates autoacetylation of p300.沉默信息调节因子2(SIRT2)去乙酰化酶调节p300的自身乙酰化作用。
Mol Cell. 2008 Nov 7;32(3):449-55. doi: 10.1016/j.molcel.2008.09.018.
10
SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90.SIRT2 通过去乙酰化和降解 HSP90 减少肌动蛋白聚合和细胞迁移。
Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1230-1238. doi: 10.1016/j.bbamcr.2018.06.005. Epub 2018 Jun 14.

引用本文的文献

1
Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical Translation.免疫治疗时代的Toll样受体:肿瘤免疫与临床转化的双刃剑
MedComm (2020). 2025 Jul 27;6(8):e70308. doi: 10.1002/mco2.70308. eCollection 2025 Aug.
2
Exosomes secreted from adipose-derived stem cells inhibit M1 macrophage polarization ameliorate chronic endometritis by regulating SIRT2/NLRP3.脂肪来源干细胞分泌的外泌体通过调节SIRT2/NLRP3抑制M1巨噬细胞极化,改善慢性子宫内膜炎。
Mol Cell Biochem. 2025 Apr 21. doi: 10.1007/s11010-025-05283-2.
3
Potential role of lactylation in intrinsic immune pathways in lung cancer.

本文引用的文献

1
Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020.选择性 SIRT2 抑制剂作为有前途的抗癌治疗药物:2016 年至 2020 年的最新进展。
Eur J Med Chem. 2021 Nov 15;224:113709. doi: 10.1016/j.ejmech.2021.113709. Epub 2021 Jul 18.
2
The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis.SIRT2-SMC1A轴的去乙酰化-磷酸化调节作为早期肿瘤发生中抗有丝分裂灾难的一种机制。
Sci Adv. 2021 Feb 24;7(9). doi: 10.1126/sciadv.abe5518. Print 2021 Feb.
3
The matrix in cancer.
乳酸化在肺癌固有免疫途径中的潜在作用。
Front Pharmacol. 2025 Mar 17;16:1533493. doi: 10.3389/fphar.2025.1533493. eCollection 2025.
4
Sirtuin 2 regulates neutrophil functions through NAD synthesis pathway in virus infection.沉默调节蛋白2在病毒感染中通过烟酰胺腺嘌呤二核苷酸合成途径调节中性粒细胞功能。
iScience. 2024 Jun 4;27(7):110184. doi: 10.1016/j.isci.2024.110184. eCollection 2024 Jul 19.
5
Harnessing innate immune pathways for therapeutic advancement in cancer.利用先天免疫途径推进癌症治疗的进展。
Signal Transduct Target Ther. 2024 Mar 25;9(1):68. doi: 10.1038/s41392-024-01765-9.
癌症中的基质。
Nat Rev Cancer. 2021 Apr;21(4):217-238. doi: 10.1038/s41568-020-00329-7. Epub 2021 Feb 15.
4
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective.肿瘤相关巨噬细胞的治疗性调控:临床与转化视角的现状与展望。
Clin Cancer Res. 2021 Jun 15;27(12):3291-3297. doi: 10.1158/1078-0432.CCR-20-1679. Epub 2021 Feb 2.
5
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.糖生物学的临床影响:靶向选择素、Siglecs 和哺乳动物聚糖。
Nat Rev Drug Discov. 2021 Mar;20(3):217-243. doi: 10.1038/s41573-020-00093-1. Epub 2021 Jan 18.
6
ADAP Y571 Phosphorylation Is Required to Prime STAT3 for Activation in TLR4-Stimulated Macrophages.ADAP Y571 磷酸化是 TLR4 刺激的巨噬细胞中 STAT3 激活的前提。
J Immunol. 2021 Feb 15;206(4):814-826. doi: 10.4049/jimmunol.2000569. Epub 2021 Jan 11.
7
NAD/NADH redox alterations reconfigure metabolism and rejuvenate senescent human mesenchymal stem cells in vitro.NAD/NADH 氧化还原状态的改变重塑了代谢,并使体外衰老的人骨髓间充质干细胞恢复活力。
Commun Biol. 2020 Dec 15;3(1):774. doi: 10.1038/s42003-020-01514-y.
8
Macrophage-Based Approaches for Cancer Immunotherapy.基于巨噬细胞的癌症免疫疗法。
Cancer Res. 2021 Mar 1;81(5):1201-1208. doi: 10.1158/0008-5472.CAN-20-2990. Epub 2020 Nov 17.
9
Concepts of extracellular matrix remodelling in tumour progression and metastasis.肿瘤进展和转移中外细胞基质重塑的概念。
Nat Commun. 2020 Oct 9;11(1):5120. doi: 10.1038/s41467-020-18794-x.
10
Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion.分泌自噬机制和囊泡运输参与了 HMGB1 的分泌。
Autophagy. 2021 Sep;17(9):2345-2362. doi: 10.1080/15548627.2020.1826690. Epub 2020 Oct 5.